ORIGINAL RESEARCH
Accepted on 05 Feb 2025
The C/EBPβ antagonist peptide Lucicebtide (ST101) induces macrophage polarization toward a pro-inflammatory phenotype and enhances anti-tumor immune responses
doi 10.3389/fimmu.2025.1522699
- 130 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Deciphering Macrophage Polarization/Transition in Human Inflammatory Disease and Cancer
Deciphering Macrophage Polarization/Transition in Human Inflammatory Disease and Cancer
202
Total downloads
1,247
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: